Want to see PURE full AI Analyst Report?
Pure Bioscience (PURE) Income Statement
Pure Bioscience Income Statement
Last quarter (Q4 2026), Pure Bioscience's total revenue was $660.00K, a decrease of 13.61% from the same quarter last year. In Q4, Pure Bioscience's net income was $-610.00K. See Pure Bioscience’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jul 26 | Jul 25 | Jul 24 | Jul 23 | Jul 22 |
|---|---|---|---|---|---|
| $ 2.32M | $ 2.20M | $ 1.96M | $ 1.88M | $ 1.85M | |
| $ 1.33M | $ 1.30M | $ 1.15M | $ 971.00K | $ 1.00M | |
| $ 3.41M | $ 3.58M | $ 4.34M | $ 4.60M | $ 4.42M | |
| Depreciation and Amortization | $ 3.00K | $ 2.00K | $ 148.00K | $ 117.00K | $ 213.00K |
| $ -2.08M | $ -2.10M | $ -3.05M | $ -3.83M | $ -3.27M | |
| $ -2.08M | $ -2.27M | $ -3.13M | $ -3.94M | $ -3.42M | |
| $ -400.00K | $ -127.00K | $ -219.00K | $ -18.00K | $ 233.00K | |
| $ -2.48M | $ -2.40M | $ -3.35M | $ -3.96M | $ -3.49M | |
| $ -2.48M | $ -2.40M | $ -3.35M | $ -3.96M | $ -3.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.02 | $ -0.03 | $ -0.04 | $ -0.04 |
| Diluted EPS | $ -0.02 | $ -0.02 | $ -0.03 | $ -0.04 | $ -0.04 |
| Weighted Average Shares Outstanding | 116.46M | 111.86M | 111.86M | 111.40M | 88.84M |
| Weighted Average Shares Outstanding (Diluted) | 116.46M | 111.86M | 111.86M | 111.40M | 88.84M |
Currency in USD
